Literature DB >> 1149255

Relative competition of corticosterone, cortisol, cortisone, 11-dexycortisol and prednisolone with (1,2-3H)-cortisol in various protein-binding radioassay systems.

A Angeli, D Bisbocci, F Melo, R Frairia, G P Gaidano.   

Abstract

The relative influence of some endogenous corticosteroids and of synthetic prednisolone on competitive protein-binding radioassay was compared with that of cortisol, using as a source of transcortin pooled plasmas from various species and at different dilutions. Human (different clinical situations), cow, dog, sheep, hog, rabbit and chicken plasma were examined. The ability of corticosterone, cortisone, 11-deoxycortisol and prednisolone to displace [1,2-3-H] cortisol from corticosteroid-binding globulin (CBG) was measured: (1) by assessing the amounts (ng/tube) which produce a displacement equal to 10 ng/tube of cortisol, and (2) by calculating the integrated areas of displacement defined by the binding curves and by expressing them as a percentage of the cortisol curve area. While corticosterone, 11-deoxycortisol and prednisolone have a binding potency not very different from that of cortisol in almost the entire set of competitive protein-binding assays tested, the binding ability of cortisone was found to be particularly dependent upon the species of diluted plasma. Differences in the relative specificity of binding are apparent also within the human species, depending on the source of diluted plasma, whereas the concentration of endogenous steroids does not seem to significantly affect binding curves under the conditions examined. It is suggested that binding proteins in various conditions differ from those of healthy adults not only quantitatively but also qualitatively.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1149255     DOI: 10.1016/0009-8981(75)90418-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Circadian profile of plasma cortisol and aldosterone in post-traumatic comatose patients under high-dose dexamethasone treatment.

Authors:  F Agrimonti; D Boggio-Bertinet; F Balzola; A Angeli
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

2.  The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.

Authors:  Rosemary Dineen; Lucy-Ann Behan; Grainne Kelleher; Mark J Hannon; Jennifer J Brady; Bairbre Rogers; Brian G Keevil; William Tormey; Diarmuid Smith; Christopher J Thompson; Malachi J McKenna; Wiebke Arlt; Paul M Stewart; Amar Agha; Mark Sherlock
Journal:  BMC Endocr Disord       Date:  2020-10-10       Impact factor: 2.763

Review 3.  Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe.

Authors:  Claire S Martin; Mark S Cooper; Rowan S Hardy
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-27       Impact factor: 5.555

4.  Humoral mediation for cachexia in tumour-bearing rats.

Authors:  L Tessitore; P Costelli; F M Baccino
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.